SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " ATM " 2,409 found 🔀 AI-powered Shuffle
Connecting Air Quality, Climate, and Health
For Jeffrey Pierce, the path to becoming an atmospheric scientist was not entirely planned. It began with an interest in math and science, an influential chemistry teacher, and an undergraduate degree…
NYCHHC GOUVERNEUR
NYC Health + Hospitals/Gouverneur provides high quality short-term rehabilitation and long-term skilled nursing services in a warm and comfortable setting. Our 295-bed Skilled Nursing Facility staff provides medical, nursing, and rehabilitative care in an atmosphere of dignity and compassion. Our multilingual, nurturing staff proudly reflects the diversity of Manhattan’s Lower East Side. NYC Health + Hospitals/Gouverneur | 227 Madison Street | New York, New York 10002 Tel: (844) 692-4692 Click here to learn more about our services. https://www.nychealthandhospitals.org/gouverneur/services/ (Virtual tour generated by Panotour)
NYCHHC GOUVERNEUR
NYC Health + Hospitals/Gouverneur provides high quality short-term rehabilitation and long-term skilled nursing services in a warm and comfortable setting. Our 295-bed Skilled Nursing Facility staff provides medical, nursing, and rehabilitative care in an atmosphere of dignity and compassion. Our multilingual, nurturing staff proudly reflects the diversity of Manhattan’s Lower East Side. NYC Health + Hospitals/Gouverneur | 227 Madison Street | New York, New York 10002 Tel: (844) 692-4692 Click here to learn more about our services. https://www.nychealthandhospitals.org/gouverneur/services/ (Virtual tour generated by Panotour)
NYCHHC GOUVERNEUR
NYC Health + Hospitals/Gouverneur provides high quality short-term rehabilitation and long-term skilled nursing services in a warm and comfortable setting. Our 295-bed Skilled Nursing Facility staff provides medical, nursing, and rehabilitative care in an atmosphere of dignity and compassion. Our multilingual, nurturing staff proudly reflects the diversity of Manhattan’s Lower East Side. NYC Health + Hospitals/Gouverneur | 227 Madison Street | New York, New York 10002 Tel: (844) 692-4692 Click here to learn more about our services. https://www.nychealthandhospitals.org/gouverneur/services/ (Virtual tour generated by Panotour)
Dartmouth Hosts Fifth Annual Digital Health Summit
At a transformative time in medicine, as wearables and interactive smartphone apps rapidly expand access to assessment and treatment beyond clinical settings, Geisel School of Medicine’s Center for…
NYCHHC GOUVERNEUR
NYC Health + Hospitals/Gouverneur provides high quality short-term rehabilitation and long-term skilled nursing services in a warm and comfortable setting. Our 295-bed Skilled Nursing Facility staff provides medical, nursing, and rehabilitative care in an atmosphere of dignity and compassion. Our multilingual, nurturing staff proudly reflects the diversity of Manhattan’s Lower East Side. NYC Health + Hospitals/Gouverneur | 227 Madison Street | New York, New York 10002 Tel: (844) 692-4692 Click here to learn more about our services. https://www.nychealthandhospitals.org/gouverneur/services/ (Virtual tour generated by Panotour)
NYCHHC GOUVERNEUR
NYC Health + Hospitals/Gouverneur provides high quality short-term rehabilitation and long-term skilled nursing services in a warm and comfortable setting. Our 295-bed Skilled Nursing Facility staff provides medical, nursing, and rehabilitative care in an atmosphere of dignity and compassion. Our multilingual, nurturing staff proudly reflects the diversity of Manhattan’s Lower East Side. NYC Health + Hospitals/Gouverneur | 227 Madison Street | New York, New York 10002 Tel: (844) 692-4692 Click here to learn more about our services. https://www.nychealthandhospitals.org/gouverneur/services/ (Virtual tour generated by Panotour)
NYCHHC GOUVERNEUR
NYC Health + Hospitals/Gouverneur provides high quality short-term rehabilitation and long-term skilled nursing services in a warm and comfortable setting. Our 295-bed Skilled Nursing Facility staff provides medical, nursing, and rehabilitative care in an atmosphere of dignity and compassion. Our multilingual, nurturing staff proudly reflects the diversity of Manhattan’s Lower East Side. NYC Health + Hospitals/Gouverneur | 227 Madison Street | New York, New York 10002 Tel: (844) 692-4692 Click here to learn more about our services. https://www.nychealthandhospitals.org/gouverneur/services/ (Virtual tour generated by Panotour)
Jon Batiste shares health update on wife's cancer battle with sweet selfie
Jon Batiste – whose wife, Suleika Jaouad, is battling cancer – shared new photos of the couple on social media amid Jaouad's treatment.
Mid-Columbia Ballet prepares for 50th anniversary of "The Nutcracker"
RICHLAND, WA. — For 50 years, the Mid-Columbia Ballet has brought the holiday classic The Nutcracker to audiences in the Tri-Cities. This year, the organization is celebrating that milestone with 144 dancers, new costumes and months of preparation to bring the beloved production to life. The annual performance is a major undertaking for the dancers, instructors and volunteers who work behind the scenes to make the show possible. Rehearsals span 13 weeks, with dancers practicing four days a week for multiple hours at a time.This year’s production will feature new costumes for the Waltz of the Flowers, including a sequence with as many as 25 dancers on stage at once. The show also brings together performers across generations, including adults who have been part of the production for more than 20 years. For Artistic Director Debra Rogo, the preparation begins long before the curtains open.Rogo has been involved with the Mid-Columbia Ballet for 40 years and says planning for The Nutcracker takes place throughout the year. While organizing a production of this size requires significant time and effort, she says watching young dancers grow and develop a passion for ballet makes it all worthwhile. “It’s why I do this,” Rogo said. “It is overwhelming ina good way. To be able to share into their lives and watch them develop a love of this art form and the hard work … it makes me very proud.”Rogo’s decades of involvement reflect the lasting impact the production has had on the local dance community. For many performers, The Nutcracker is more than a seasonal performance. It is an opportunity to build skills, create relationships and become part of a tradition that continues year after year.While the dancers spend weeks rehearsing their routines, a large team of volunteers works behind the scenes to support the production.More than 100 volunteers are involved this year, helping make the performance possible. Their contributions reflect the range of people who come together to support the arts in the Tri-Cities.Randy Haven, a longtime volunteer, says the sense of community is one of the things that makes the experience so special.“The people that you hear volunteering, it’s incredible,” Haven said. He described seeing people from different backgrounds working together backstage, from employees at Hanford to parents raising large families.Haven says that shared commitment creates a family-like atmosphere among the people involved in the production. For Rebecca and Torrie, the Mid-Columbia Ballet has been part of their lives since childhood. Both began dancing with the organization at age seven and have since returned as teachers, helping introduce the next generation to the art form.Their connection to the ballet has continued into their adult lives, creating an opportunity to share their love of dance with younger performers.Torrie now has three daughters performing in The Nutcracker, giving her the chance to watch them experience a tradition that was also part of her own childhood.Being able to see her daughters participate in the production has made the experience especially meaningful, she said.Although audiences can see productions of The Nutcracker in major cities such as New York and Seattle, those involved with the Mid-Columbia Ballet say the local performance offers something distinctive.The community atmosphere allows audiences to experience the production while supporting local performers and the people who dedicate their time to the arts.Rebecca says experiencing a live performance alongside other people is particularly meaningful in a world where so much time is spent looking at screens.She believes live art gives people an opportunity to connect with one another through a shared experience.The ballet’s production also gives local dancers the chance to perform for their community while continuing a tradition that has been part of the Tri-Cities for five decades. When to see ‘The Nutcracker’ in RichlandThe Mid-Columbia Ballet will present its 50th-anniversary production of The Nutcracker Dec. 10 through Dec. 13 in Richland.Tickets go on sale Nov. 1. Audiences can look forward to seeing 144 dancers, new costumes and the work of more than 100 volunteers come together for the holiday production.COPYRIGHT 2026 BY APPLE VALLEY NEWS NOW. ALL RIGHTS RESERVED. THIS MATERIAL MAY NOT BE PUBLISHED, BROADCAST, REWRITTEN OR REDISTRIBUTED.
Scientists Tested a Toad Venom Psychedelic on Treatment-Resistant Depression. Here's What Happened.
A clinical trial shows promising results, but many questions remain.
New zebrafish models could help test treatments for mental health conditions
A humble fish can experience features of mental health conditions such as schizophrenia and autism, raising the possibility that some of our most complex social behaviors may be more deeply encoded in ...
Robert Pattinson says he's "so happy" Steven Soderbergh will complete filming on The Batman 2: "To have someone who's as talented as Steven doing it is great"
Exclusive: Primetime star Robert Pattinson tells GamesRadar+ about completing filming on The Batman 2 with director Steven Soderbergh
SCC To Host Modern Hair Care Science: From Follicle to Formulation
The majority of the program focuses on formulation strategies for key product categories including shampoos, conditioners, styling products and scalp treatments.
4 Supplements That Science Says Could Boost Your Mood
They’re not a replacement for mental health treatment, but they could provide support.
Scientists solve mystery of 1,000-mile cloud floating on Mars
Space enthusiasts and astronomers have been tracking one of the Red Planet’s most fascinating atmospheric mysteries for years: a colossal plume officially known as the Arsia Mons Elongated Cloud (AMEC). AMEC was first discovered in 2018 and quickly became one of the most elusive answers for scientists. Researchers have now resolved this mystery using the […] Read the original article here: Scientists solve mystery of 1,000-mile cloud floating on Mars
How ‘Clayface’ created the creature’s final form
‘Clayface’ team breaks down Matt Hagen’s final transformation into the creature of Batman’s rogues’ gallery.
Intuition pushed mom to keep checking for breast cancer
Michigan mom had no reason to suspect cancer. But instinct nudged her to find out for sure — and carried her through challenging treatments to remission.
A game-changing new treatment just arrived for one of the deadliest cancers — here's why doctors are so excited
Bass and Raman skirmish over treatment of small business. The Valley is a battleground
L.A. mayoral candidates Bass and Raman skirmish over their support for small businesses. The San Fernando Valley is a battleground
Bass and Raman skirmish over treatment of small business. The Valley is a battleground
L.A. mayoral candidates Bass and Raman skirmish over their support for small businesses. The San Fernando Valley is a battleground
Bass and Raman skirmish over treatment of small business. The Valley is a battleground
L.A. mayoral candidates Bass and Raman skirmish over their support for small businesses. The San Fernando Valley is a battleground
How to Manage Symptoms of Heart Failure
(Feature Impact) Americans are facing a growing health challenge, with 1 in 4 adults at risk of heart failure, according to the Heart Failure Society of America. Additionally, approximately 6.7 million U.S. adults who are 20 years old or older are currently living with heart failure, and that number is projected to reach 8.7 million by 2030. googletag.cmd.push(function() { googletag.display('JGFI_Article_300x250'); }); Managing heart failure is a significant expense to the U.S. healthcare system, costing the nation approximately $40 billion in 2020 and expected to increase to approximately $142 billion a year by 2050.If you (or a loved one) are living with the condition, consider these tips to help manage it.Adhere to the Treatment and Follow-Up PlanOngoing outpatient care is important when managing heart failure. Understand the treatment plan provided by your healthcare team, make diet and lifestyle changes, take medications as directed and keep recommended follow-up appointments.Pay attention to changes in symptoms and communicate with your healthcare provider if treatment does not seem to be working as expected. If their conditions are left unmanaged, patients can experience a range of heart-failure-related symptoms such as shortness of breath, fatigue, buildup of fluid and more.Understand Challenges with Diuretic TreatmentDiuretics help the body remove excess fluid and are commonly used to treat swelling, or edema, associated with heart failure. Your provider may try different diuretics, sometimes referred to as “water pills,” to manage your heart failure symptoms. However, intravenous (IV) diuretic therapy may be required for some patients if symptoms continue.Ask About Treatment Options Before IV Care Is NeededFor some adults, a healthcare provider may consider recommending an at-home, non-oral diuretic option prior to escalating to IV therapy.For example, ENBUMYST™ (bumetanide nasal spray) is a prescription diuretic used in adults to treat edema associated with congestive heart failure. It’s administered as a nasal spray for short-term use to manage excess fluid with the goal of transitioning to oral diuretic therapy when appropriate.Talk with your healthcare provider to learn more and visit enbumyst.com. Read the full Prescribing Information and Patient Information.Photo courtesy of Shutterstock googletag.cmd.push(function() { googletag.display('JGFI_Article2_300x250'); }); Important Safety InformationWhat is ENBUMYST?ENBUMYST is a prescription medicine used in adults to treat swelling caused by excess fluid in the body (edema) from congestive heart failure, liver disease, and kidney disease.What is the most important information I should know about ENBUMYST?ENBUMYST is a diuretic that helps your body remove fluid. Losing too much fluid can cause dehydration, low blood volume, and increase the risk of blood clots. Blood abnormalities may include decreased salts (electrolytes), and increased nitrogen, glucose and uric acid. The risk of these abnormalities is higher in elderly people, those using higher doses, or those who do not get enough electrolytes by mouth.You should not use ENBUMYST if you have severe electrolyte loss. Tell your healthcare provider if you experience unusual thirst; dizziness or lightheadedness; weakness or tiredness; fast heart rate; dry mouth or tongue; sudden pain; redness or swelling in your joints; pain, swelling, redness, or warmth in your leg; shortness of breath or fast breathing; high blood sugar; dark urine; pale, tight, cool or clammy skin; muscle cramps; confusion.Do not use ENBUMYST if you have low or no urine production or are allergic to bumetanide or to any of the ingredients in ENBUMYST.Before using ENBUMYST, tell your healthcare provider if you have low electrolytes, are on a low-salt diet, have diarrhea, diabetes, nasal problems such as a runny or stuffy nose or polyps, a history of nasal injury or surgery, are or plan to become pregnant, are or plan to breastfeed.Tell your healthcare provider about all the medicines you take, including prescriptions, over-the-counter medicines, vitamins, and herbal supplements.ENBUMYST may cause serious side effects, such as worsening kidney function and ringing in the ears or hearing loss.The most common side effects of ENBUMYST include dehydration, headache, muscle cramps, dizziness, low blood pressure, nausea, and abnormal brain functioning with certain liver problems.These are not all the possible side effects of ENBUMYST. Talk to your healthcare provider for more information.Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.US-ENBU-2600110 googletag.cmd.push(function() { googletag.display('JGFI_Article3_300x250'); });
Understanding Gastroparesis
Hunting for a diagnosis — and treatment — when your stomach won’t empty.
ATM stolen from business in Brighton Park, Chicago police say
Chicago police are looking for the people who stole an ATM from a convenience store Sunday morning on the city's Southwest Side.
How Republican anti-Muslim politics gets built into US cities
Republican anti-Muslim rhetoric can turn religious prejudice into zoning barriers, making equal treatment for all citizens a test of democracy
Martin Ignacio Zapata Laguado: Negative Trial in Newly Diagnosed Glioblastoma at ESMO26
Martin Ignacio Zapata Laguado: Negative Trial in Newly Diagnosed Glioblastoma at ESMO26 / cancer, cancer care, cancer treatment, ESMO26, glioblastoma, Martin
Elizabeth Holmes film puts up a fight against 'Clayface' at box office
A movie set in the world of Batman and a three-hour documentary about Elizabeth Holmes went head-to-head at the box office this weekend, and it turned out to be a closer contest than expected.
Elizabeth Holmes film puts up a fight against 'Clayface' at box office
A movie set in the world of Batman and a three-hour documentary about Elizabeth Holmes went head-to-head at the box office this weekend, and it turned out to be a closer contest than expected.
The Future of IBD Treatment: 4 Promising Therapies to Know About
New treatments are in development for inflammatory bowel diseases like Crohn’s disease and ulcerative colitis. Find out what experts say you should know.
"It never was entertainment to us, ever. It was always something with a lot more importance and meaning." U2 reveal the unbroken promise that they made to one another as schoolboys in Ireland 50 years ago
"Music is not a matter of life and death, it’s something much more serious than that"
ESMO: Roche touts ‘convincing’ phase 3 KRAS data after win over rivals
Roche has shed more light on its investigational KRAS G12C inhibitor's phase 3 victory over Amgen’s Lumakras and Bristol Myers Squibb’s Krazati. The open-label Krascendo 1 trial enrolled 338 people with previously treated KRAS G12C-mutated non-small cell lung cancer (NSCLC). Patients who had already received a KRAS G12C inhibitor or pan-KRAS/RAS inhibitor were excluded from the trial. Participants received either divarasib once daily, Lumakras once daily or Krazati twice daily. Roche announced back in July that divarasib had demonstrated statistically significant improvements in progression-free survival (PFS) and overall survival (OS), meeting the trial’s primary and key secondary endpoints. But the Swiss pharma had been holding back the detailed data until now. At the European Society for Medical Oncology (ESMO) Congress in Madrid, Roche revealed that median OS for the 167 patients who received divarasib was 17.7 months, compared to 12 months for the 171 patients who received Lumakras or Krazati. The benefit was similarly clear when it came to median PFS, which stood at 9.8 months versus 5.7 months, respectively. A total of 44% of patients receiving divarasib were alive without disease progression at one year, compared to 24% of the control group, according to Roche’s presentation. It was a similar story for the objective response rate, which came in at 58% for divarasib versus 32% for the control group, while median duration of response was 11.9 months versus 6.9 months. Stefan Frings, M.D., Ph.D., deputy chief medical officer at Roche Pharma, told Fierce that the data made for a “very comprehensive, strong package, which should be convincing to health authorities.” “It’s an important advance for patients with lung cancer,” Frings said in an interview at a Madrid hotel during the conference. “It's a second-line setting, and patients who receive divarasib benefit compared to the current first-generation KRAS G12C inhibitors by having far longer overall survival,” he continued. “They live longer. They have better progression-free survival, better response rates, and with a safety profile which is—if [anything]—even better,” he said. According to Roche, 4.8% of patients receiving divarasib discontinued treatment due to treatment-related adverse events, compared to 11.7% in the control group. Serious treatment-related adverse events were also less common with divarasib, at 7.8% versus 15.2%. Roche’s confidence in divarasib had been building even before this phase 3 success. The candidate had already shown better potency and selectivity than the incumbent KRAS G12C inhibitors Krazati and Lumakras in preclinical tests. After cross-trial comparisons suggested that the edge translated into better clinical outcomes, Roche axed a study comparing divarasib to the chemotherapy docetaxel and went toe-to-toe with Lumakras and Krazati. “We designed the drug on purpose with higher potency and better selectivity,” Frings explained. “So, based on preclinical models, we clearly knew it would be superior to the first generation.” “It’s honestly not so frequent that pharma companies go head-to-head,” he added. “But if you want to make a point, if you want to convince payers, prescribers and patients … then a head-to-head win is rather rewarding.” While Amgen and BMS reached the regulatory finish line first for KRAS G12C-mutated, locally advanced or metastatic NSCLC in 2021 and 2022, respectively, they have struggled to capitalize on their head start. Krazati brought in $55 million for BMS in the second quarter, while Lumakras delivered $111 million to Amgen. For its part, Roche is aiming for peak divarasib sales of 1 billion to 2 billion Swiss francs ($1.2 billion to $2.5 billion), according to Frings. The Big Pharma is currently recruiting patients into a phase 3 trial comparing divarasib plus Keytruda against Keytruda plus chemotherapy in previously untreated advanced or metastatic nonsquamous KRAS G12C-mutated NSCLC. Roche has previously suggested that sales in metastatic disease would account for most of the forecast. Frings was tight-lipped on the exact timeline for a regulatory filing but said the Swiss pharma is “certainly keen to get this to as many patients as possible around the world.” Roche has more RAS drugs coming up behind divarasib. The pharma has already launched phase 1 trials of a pan-RAS inhibitor called RG6505 and a KRAS G12D inhibitor dubbed RG6620 in solid tumors. Roche’s partner Chugai Pharmaceutical is also testing a pan-KRAS inhibitor called AUBE00. Roche has made a “deliberate effort” to test a range of RAS drugs, Frings said. “If you have many rare mutations and you are scrambling to find sufficient patients, a pan-RAS inhibitor makes a lot of sense,” he explained.
A simple liquid can stop cavities without drilling, major study confirms
A simple liquid painted onto teeth in seconds can stop cavities without drilling, injections, or anesthesia, according to a major clinical trial involving young children. The inexpensive treatment could spare thousands of children painful dental procedures and surgery while paving the way for broader FDA-approved use.
Health Ministry announces national clinical trial of psychedelic substances for treatment of PTSD
* * *
South Texas Health System (@stxhealthsystem)
2 likes, 1 comments - stxhealthsystem on October 25, 2026: "One Last Chance to Think Pink: Breast cancer remains the most common cancer among women after skin cancer, making routine screenings and early detection more important than ever. Mammograms can help identify breast cancer before symptoms appear, when treatment options may be most effective. Last week, South Texas Health System McAllen celebrated breast health and preventive care with a special Mammo Monday event featuring the vibrant sounds of mariachi music at the hospital’s main entrance. The celebration reflected STHS' ongoing commitment to encouraging women to prioritize their health through regular screenings. Now, there’s one final Mammo Monday remaining! Join us at STHS ER Mission on October 26 from 8 a.m. to 5 p.m. for the last breast cancer event of 2026. During the event, attendees can: 🎀 Learn about breast cancer screening options 🎀 Schedule a mammogram appointment 🎀 Receive a complimentary goodie bag while supplies last To help make preventive care more accessible, South Texas Health System is also offering reduced self-pay rates* throughout October: • 2D Mammogram: $100 • 3D Mammogram: $155 • Bone Density Screening: $160 A screening today could make all the difference tomorrow. Make your health a priority and encourage the women you love to do the same. For breast health resources and information on the Think Pink campaign, visit the link in our bio. *If not already a covered benefit of your insurance.".
Powers Health Community Hospital Achieves Statewide Milestone in Treating Heart Valve Conditions
Powers Health Community Hospital has successfully performed Indiana’s first procedure using the SAPIEN M3™ transcatheter mitral valve replacement (TMVR) system, a minimally invasive treatment for …
Longview summit to bring together mental health, substance abuse treatment providers - Longview News-Journal
The East Texas Council on Alcoholism and Drug Abuse will bring together mental health experts, substance abuse treatment providers and more during a Nov. 4 conference in Longview. The East […]
Scientists discover how pancreatic cancer rewrites its DNA to escape treatment
Scientists have discovered how pancreatic cancer cells continually reshape their genetic makeup to become more aggressive, spread, and evade treatment. In laboratory experiments, blocking a key gene reversed some of these dangerous changes, revealing a potential new way to fight the deadly disease.
Common Liver Disease May Actually Have 5 Distinct Types With Different Health Risks
Each may need their own treatments.
Common Liver Disease May Actually Have 5 Distinct Types With Different Health Risks
Each may need their own treatments.
Reality TV star Anika Rashaun dead at 34
Reality TV star Anika Rashaun, who appeared on ‘The Real World’ and ‘The Challenge,’ has died at 34.
South Texas Health System (@stxhealthsystem)
1 likes, 1 comments - stxhealthsystem on October 24, 2026: "Lower Your Risk, Prioritize Your Breast Health: Breast cancer is one of the most commonly diagnosed cancers among women worldwide. While some risk factors, such as age and family history, can't be changed, there are lifestyle choices that may help reduce your risk and support overall breast health. ✅ Maintain a healthy weight ✅ Stay physically active ✅ Eat a balanced, nutritious diet ✅ Avoid tobacco & limit alcohol consumption ✅ Talk with your doctor about hormone replacement therapy Just as important, don't delay routine checkups and recommended screenings. When breast cancer is detected early, treatment is often more effective and outcomes can be significantly improved. For more on breast cancer, watch the latest South Texas Health Minute on ValleyCentral.com at the link in our bio.".
At one Atlanta restaurant, workers are family. A health insurance crisis tested that commitment
Jen and Emily Chan offer insurance to full-time employees at their restaurant. But those costs soared after Jen’s breast cancer treatment and another employee’s surgery.
Larry the Cable Guy takes aim at corporations that considered his Southern brand ‘too controversial’
Daniel Whitney, known as Larry the Cable Guy, calls out corporate hypocrisy on during a podcast appearance, comparing his treatment to other popular rapper's deals.
Could lowering high blood pressure be as simple as stimulating your ear?
A small device that gently stimulates nerves through the ear could offer a new way to tackle stubborn high blood pressure. In a clinical trial of 63 patients already taking medication, the treatment proved safe, easy to use at home, and well tolerated. Although it did not significantly outperform a placebo overall, patients with more severe hypertension showed promising reductions in blood pressure.
Tampa General Hospital and Health Care District of Palm Beach County to Open Lakeside Cancer Center in September 2027, Expanding Access to Academic-Based Cancer Care in Florida’s Rural Communities - Florida Hospital News and Healthcare Report
Lakeside Cancer Center will connect cancer patients in the Glades with world-class treatment, complex care coordination and access to oncology specialists. October Tampa General Hospital and Health Care District of […]
The Ripple Effect: How Abortion Bans Threaten the Entire Healthcare Ecosystem
Abortion bans are disrupting access to medications, miscarriage care, fertility treatments and medical research.
Christina Applegate's MS misdiagnosis after 5 years of treatment exposes alarming medical reality
Christina Applegate's MS misdiagnosis highlights how brain lesions and common symptoms can mislead doctors, with nearly one in five referrals wrong.
Omaha Tribe opens $8.5M water treatment plant, quadrupling capacity
The Omaha Tribe of Nebraska has opened the Umóⁿhoⁿ Ní Waxúbe — Omaha Sacred Water Treatment Facility, Ní Ti, an $8.5 million plant that quadruples water storage capacity, according to utility director Jerry Henscheid. The facility came online Oct. 6 on the Omaha Reservation in northeastern Nebraska, replacing a plant built in 1980 that had […]
Improving breast cancer treatment; improving prostate cancer diagnosis; listen to your knee pain; plus other stories with Vanderbilt Health sources
WTVF News Channel 5’s “Morningline” program interviewed Denise Garcia, MD, Assistant Professor of Surgery, about new technology that helps surgeons identify cancer during surgery and improve breast cancer treatment. A Men’s Health story about PSA screening for prostate cancer quoted Kelvin Moses, MD, PhD, Professor of Urology. Men’s Health posted a story, “What Your Knee Pain is Trying to Tell You,” that quotes Charles Cox, MD, MPH, Associate Professor of Orthopaedic Surgery. William Schaffner, MD, Professor of Preventive Medicine, was quoted by several news outlets about public health issues, including: WSMV Channel 4 News (importance of flu shots); MedPage Today (mRNA flu shots); WTVF News Channel 5 (19 people sent to hospital after a sickness outbreak at Walmart facility in Lebanon); Prevention (West Nile virus); HuffPost (prevention pill for COVID); and Newsweek (measles cases continue to increase in the U.S.). Becker’s Hospital Review and Nashville Post covered the Vanderbilt Health News story from Rebecca Warren that Chief Communications Officer John Howser is retiring in March 2027, closing out a nearly 40-year career at Vanderbilt. A Healio story on research about OCT-A biomarkers and diabetic retinopathy quotes Vanderbilt University School of Medicine student Rachel Liu. WPLN Nashville Public Radio quoted Amanda Mixon, MD, MPH, Associate Professor of Medicine, in a story about adverse drug interactions.
Stand Up for Science Covers the Accidental Path to Prozac in the Latest “Traces Thursday” Installment
How an allergy pill reshaped the treatment of depression
This week in health care policy: October 16–23, 2026
Medical innovation FDA approves several innovative treatments. Last week, the FDA granted accelerated approval to GSK’s Jemperli for certain untreated cancers with a specific DNA defect. The treatment will eliminate the need for costly alternative treatments such as surgery, radiation, or chemotherapy, which are known to cause lasting health problems. The FDA also approved GSK’s […]
Health spending on Southampton taxis surges by 75%
It comes as the department looks to review spending for off-island hospital treatment.
Beyond cigarettes: Uncovering the causes of lung cancer in nonsmokers
The disease’s rising incidence among nonsmokers is prompting greater research into its unique characteristics and hopes for more targeted screening and treatment.
Breast Cancer Care and Heart Health: What Black Women Need to Know
Black women face disproportionately high rates of heart disease and breast cancer mortality. Understanding how both are connected can help women advocate for screening, treatment and follow-up, say experts with Baptist Health.
DOJ charges 15 for $2 billion in fraudulent health care claims in California
The largest of the cases involved $1.6 billion in billings for what the DOJ described as “sham substance abuse treatment” in Southern California.
Aetherion Expands Houston Industrial Water Treatment Business
Aetherion expands its Houston water treatment operations. Workforce growth and added services support its strategy to acquire regional providers.
Feds allege $2 billion in California health care fraud, 15 charged
Federal authorities announced charges against 15 people, including six medical professionals, accusing them of health care fraud schemes worth $2 billion, including sham substance abuse treatment programs, unnecessary medical procedures and bogus hospice services.
Japanese Scientists Find Method to Support Sustainable Polyester Recycling
The process uses a supercritical carbon dioxide treatment.
Canine cancer patients contribute to next-generation minimally invasive cancer therapies for dogs and humans
Oncologists at Purdue University pioneer protocols for tumor ablation, a less invasive cancer treatment more effective than surgery, radiation or chemotherapy, benefiting dogs and humans alike.
HEALTH FIRST: Novant Health surgeon stresses early detection in breast cancer care
October is Breast Cancer Awareness Month, a time to highlight the importance of screening, early detection and advances in treatment.
HEALTH FIRST: Novant Health surgeon stresses early detection in breast cancer care
October is Breast Cancer Awareness Month, a time to highlight the importance of screening, early detection and advances in treatment.
Employers Shift Rising Health Care Costs Onto Millions of Workers
New surveys show that increases in premiums and deductibles are forcing people to forgo treatments or doctor’s visits while budgets are strained by higher food and gas prices.
New unit aims to fill gaps in mental health care for NC youth in juvenile detention
The 10-bed unit will provide intensive treatment to young people with acute behavioral health needs who struggle to find placement in other facilities.
Tracking tsunamis triggered by extreme weather
As much of Western Europe faced record-breaking temperatures and extended drought this summer, Croatia experienced another weather event that could also set a worrisome precedent.Over the course of two weeks, a series of meteorological tsunamis (meteotsunamis) struck Croatia’s Adriatic coast, alarming both residents and tourists. Social media posts showed flooded seaside promenades and people walking through knee-deep water. Fortunately, no deaths or major damage were reported.In a world where natural disasters seem to be increasing, meteotsunamis — tsunamis caused by rapid weather changes – rarely make headline news. But warming sea temperatures and changing atmospheric conditions may help explain why these phenomena could become more common, especially in shallower seas and inland lakes with wide coastal shelves.“We have definitely become more aware of them, and there have been a lot more reports of these events in the last 10 years,” says Jadranka Šepić, an associate professor of environmental physics at the University of Split whose research focuses on efforts to track meteotsunamis in real time. She is also one of Croatia’s ambassadors for Science Comes to Town (SCTT), a European Commission-funded programme aimed at making research more accessible to the public.Šepić sees two possible reasons for the apparent increase in meteotsunamis. One is that photos and videos shared on social media are providing more empirical evidence, while rising air and sea temperatures could also play a role. The geophysicist “cannot say with certainty” that warming is a contributing factor because research is still ongoing. “But I can say that previously in Croatia we might have had one exceptionally strong event every 10 or 15 years, and one strong event every five years, and within 15 days this summer we had five strong events,” Šepić notes. “This is not typical.”‘A fist against the sea surface’Unlike tsunamis that are triggered by underwater earthquakes or volcanoes, meteotsunamis are caused by sudden changes in atmospheric pressure combined with other rapidly developing weather events, such as thunderstorms. The effect “is like pushing a fist against the sea surface,” Šepić explains. The resulting oscillation intensifies as it reaches shallower water, and “can be far more destructive than a wind-driven wave because meteotsunamis are accompanied by very strong currents than can penetrate much deeper inland.” The meteotsunami, she continues, “then behaves the same as a tsunami — they slow down and grow as the sea shallows, and then grow further in places like harbours due to further shallowing and narrowing. When they come ashore, they can be very destructive — taking everything with them out to sea and then taking it back.”Croatian research institutions have tracked such sea oscillations since the 1930s because the relatively shallow Adriatic Sea is prone to meteotsunamis. The strongest recorded so far was in June 1978, according to the Adriatic Meteotsunami Catalogue, which is supported by the European Research Council (ERC), Croatian Science Foundation and the country’s leading research institutions. During that event, six-metre-high waves flooded the coastal town of Vela Luka on Korčula Island, causing major damage.Other meteotsunami “hotspots” in Europe include the Mediterranean Sea as well the Atlantic coastal shelves off France, Portugal and Spain. In June 2006, a meteotsunami with five-metre-high waves swept through the harbour of Ciutadella in Spain’s Balearic Islands, causing widespread damage to boats. Several less powerful events were reported in the Balearics and off the coast of Spain this summer, leading to some beach closures.Forecasting is challenging because of how quickly meteotsunamis can develop and their uncertain trajectory. Šepić is involved in two ERC-funded research projects — SHExtreme and MeD-Track — aimed in part at strengthening monitoring and real-time data collection. Access to accurate and immediate information is essential for early-warning systems.Early exposure to meteotsunamisŠepić first learned about meteotsunamis from her parents while growing up in Croatia. She later had the opportunity to investigate these events during her master and doctoral studies in geophysics at the University of Zagreb. The geophysicist has also conducted research at the Institute of Oceanography and Fisheries in Split, the University of the Balearic Islands in Palma de Mallorca and the Institute of Ocean Science in the Canadian province of British Columbia.Projects like SCTT are important to raise awareness about research and inspiring young people to pursue studies and careers in science, notes Šepić. She credits her colleagues at the University of Split and the Institute of Oceanography and Fisheries for their community outreach and engagement in the European project, which includes partner universities and institutions in Brest (France) and Kiel (Germany). As an example of town-gown collaboration, Šepić highlights her own university’s ‘Oceanographers on the Island’ programme. This initiative offers workshops and hands-on learning for children living on numerous Croatian islands.“It is a great privilege for Split to be involved in a project like Science Comes to Town, which is the first of its kind in the European Union," Šepić says. As for encouraging new generations of scientists, “This is a great effort, and I hope that we will see an effect in a few years.”Science|Business, which connects policymakers, academics and industry through its news reporting, analysis and events, is an SCTT partner.
Pope Leo won’t need additional treatment after cancer surgery
Doctors removed the lower lobe of the Chicago-born pontiff's right lung.
Christina Applegate’s Health Journey, From Early MS Symptoms to Learning She was Misdiagnosed
After years of treatment, hospitalizations and pain, the actor says her misdiagnosis isn’t welcome news.
Supreme Court rejects Trump's order to end hormone treatments for transgender prisoners
The decision is a rare win for trans rights at the Supreme Court.
Glendale business owner sues federal government over 2025 raid
Mario Ayala said he is trying to keep the business running, but the uncertainty and damage from the raid has taken a toll.
UC Davis Health introduces five-day accelerated treatment for severe depression
UC Davis Health has added an accelerated treatment approach for depression at its Advanced Psychiatric Therapeutics (APT) clinic in East Sacramento.
How a photo of a person’s face could help predict whether they’ll survive cancer treatment
A simple selfie could hold surprising clues to your overall health and longevity, especially among people with cancer.
Rare solar radiation storm gives scientists clearest picture yet of flight risks
The most comprehensive data set ever collected from Earth's atmosphere during a solar radiation event has highlighted the importance of better-coordinated radiation monitoring for aviation safety, according ...
Would subsidizing weight-loss drugs make health care fairer?
GLP-1 medicines such as Ozempic, Wegovy and Mounjaro have transformed the treatment of obesity, but access to them in Australia increasingly depends on something much less medical: whether you can afford ...
Seniors Left Waiting as Treatment Bill Faces Uphill Climb
This is an exclusive BHB+ story. Many adult seniors have been locked out of accessing residential addiction treatment for the sector's entire
Seniors Left Waiting as Treatment Bill Faces Uphill Climb
This is an exclusive BHB+ story. Many adult seniors have been locked out of accessing residential addiction treatment for the sector's entire
Meta tells Brazil's electoral court it gives equal treatment to Lula and Flávio Bolsonaro
Meta said it had "completed the implementation of measures to comply with the directive from the electoral court."
Axena Health Named Finalist for the Digital Health Hub Foundation - Digital Health & AI Awards 2026 at HLTH
NEWTON, Mass., October 20, 2026--Axena Health, Inc. (Axena Health), a women’s health company redefining the standard of care for pelvic health conditions through clinically proven, non-invasive treatments, today announced it has been named a finalist for the Digital Health Hub Foundation – Digital Health & AI Awards 2026 at HLTH. Selected from a pool of more than 1,300 participating companies across all tracks and categories, Axena Health is recognized in the Best in Class Track for Women’s and
AES Show 2026: Industry Panel Examines Live Entertainment Delivery in Dolby Atmos
As concerts and other live performances reach audiences through global streaming platforms, Dolby Atmos is opening new possibilities for immersive entertainment at home. At the upcoming AES Show Nashville, From...
HOMETOWN HEALTH: Researchers identify new clues for treating type 2 diabetes
The study's authors say this could be developed into new treatments that could help people regulate their blood sugar.
The National Landscape of Mental Health Treatment Courts
A national survey examines the growth of mental health treatment courts and the need for clearer standards, better data, and sustainable funding.
Could AI Use a Simple Photo of Your Face to Reveal Clues About Your Health?
A new AI model can estimate biological age and predict cancer survival outcomes using a simple photo of a patient’s face, though more research is needed before doctors will be able to use it to help them decide on treatments.
Australian Visitor Grateful to Holy Cross Health for Saving Her Life During Fort Lauderdale Visit - Florida Hospital News and Healthcare Report
Nearly 10 months after receiving emergency treatment at Holy Cross Health for a ruptured brain aneurysm, Australian resident Sarah Frost is reflecting on her recovery and the care that helped […]
Guided search helps Kentuckians navigate treatment, mental health and recovery resources
A new guided search feature from FindHelpNow.org makes it easier for Kentuckians to find substance use disorder treatment, mental health care and recovery resources that fit their needs.
Pfizer makes ‘business decision’ to end phase 2 trial of autoimmune drug as program’s future uncertain
Pfizer has called time on a phase 2 trial of its CXCR5 antibody in an autoimmune blood disorder, with the company tight-lipped on whether this marks the end of the road for the asset. The Big Pharma had been evaluating the therapy, dubbed PF-06835375, in a phase 2 study of 61 patients with primary immune thrombocytopenia (ITP) that kicked off in 2022, according to the federal trials register. However, Pfizer confirmed to Fierce on Monday that this study had been terminated “due to a business decision.” “The decision to terminate the trial was not based on any safety concerns,” a spokesperson pointed out. At time of publication, PF-06835375 remained listed on Pfizer’s website for both ITP and lupus. A phase 1 study in lupus wrapped up in 2022, according to the trials database. ITP is an autoimmune disorder characterized by a low platelet count. Novartis was at one point evaluating its B-cell-depleting antibody ianalumab—recently approved as Fabhalta to treat immunoglobulin A nephropathy—as a potential treatment ITP. But the therapy struggled to demonstrate a benefit in the clinic for this indication. When contacted by Fierce, Pfizer wouldn’t confirm whether all work on PF-06835375 has been halted, and whether the company has any other plans to explore C-X-C chemokine receptor type 5 (CXCR5) as a mechanism. CXCR5 is found in blood cancers such as diffuse large B-cell lymphoma and mantle cell lymphoma chemokine receptor. However, there is little expression in normal tissue, which has led some drug developers to explore its potential. Vincerx Pharma had at one point been planning to take an anti-CXCR5 ADC into the clinic to treat B-cell malignancies, but that ambition was scrapped due to cash constraints. Where Big Pharma is placing its bets is one of the hot topics being discussed at Fierce Biotech's high-impact event in London next month. Find out more information and register by clicking on the banner below: [ ](https://qtxasset.com/quartz/qcloud5/media/image/where_big_pharma_is_placing_its_bets.png?VersionId=B8JrRbJ.pFUSK1pJgjeWHLGm_18RdLAy)
GLP-1 Drugs and Mental Health: Effects on Depression and Anxiety
GLP-1 receptor agonists affect pathways involved in mood, appetite, and reward, prompting research into their potential benefits for depression, substance use disorders, and binge eating. Psychiatric treatment benefits remain unproven, while conflicting observational findings and reassuring trial evidence require careful interpretation.
Fairfield leaders discuss C-PACE financing tool that could help businesses, proposed data center
Fairfield city leaders are looking into a new financing tool that could help business and property owners pay for upgrades on commercial buildings, including the proposed Patmos data center.
Low Testosterone Opens the Door to a Broader Health Conversation
Low testosterone can signal broader health concerns involving weight, metabolic health, sleep and lifestyle. Cleveland Clinic’s Mark Paulos, MD, explains why comprehensive evaluation and a whole-person treatment approach matter.
Payson woman fights for coverage after health plan drops her provider, leaving her with $13K bill
Consumers have some protections when their insurance drops coverage during treatment.
Dog cognitive decline treatment: USF Health develops new gene therapy
Researchers at the University of South Florida are developing a gene therapy injection aimed at treating canine cognitive decline. The team hopes the one-time treatment will target the disease directly and give pets more quality time with their families.
AI facial health recognition tools help physicians assess age and survival risk to guide personalized treatment
Researchers are using AI tools to analyze simple facial photographs to determine key indicators of a person's health. Mass General Brigham researchers built FAHR-Face (Foundation Artificial Intelligence ...
President Trump signs executive order aimed at improving women's health. How could it impact you?
President Trump signed an executive order creating a women's health task force and a division at the National Institutes of Health to advance research, diagnostics, and treatments for women's health issues.
President Trump signs executive order aimed at improving women's health. How could it impact you?
President Trump signed an executive order creating a women's health task force and a division at the National Institutes of Health to advance research, diagnostics, and treatments for women's health issues.
AI facial health recognition tools help physicians assess age and survival risk to guide personalized treatment
Mass General Brigham researchers trained a new AI foundation model on more than 40 million facial images, and used it to develop AI tools to estimate biological age and directly predict survival risk in patients with cancer
Jesse Eisenberg claims he couldn’t get ‘movie studio parts anymore’ after “Batman v Superman”
The Oscar-nominated actor, screenwriter, and director said he began penning films “just to kind of keep my career afloat.”
New UI clinic pilots exercise treatments to improve health of cancer patients, survivors
A new exercise oncology research clinic at the University of Iowa is helping people dealing with cancer and its aftermath build back strength and trust in their bodies through exercise training.
HOMETOWN HEALTH: New menopause care guidelines aim to improve treatment options
Doctors say awareness of menopause is spreading, but so is misinformation.
TriGemX Bio and TCGX Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Company to Develop Elismetrep, A Potential First-in-Class Treatment for Migraine
TriGemX Bio, a biotechnology company focused on developing elismetrep, a potential first-in-class treatment for migraine, and TCGX Acquisition Corp. (Nasdaq:...
AI recommended your brand. Did it get your business right?
Marketers must evaluate the accuracy, context and destination of AI recommendations rather than relying solely on visibility metrics.
Combination nucleic acid therapies: towards personalized cancer treatment
Combination strategies enable simultaneous activation and silencing of key target genes to correct molecular pathways in pancreatic cancer.
Obama calls Trump officials’ investigation of Ilhan Omar ‘appalling’
The former president posted a lengthy statement calling President Donald Trump’s treatment of Ilhan Omar a “transparent” effort to intimidate her.